Post-marketing surveys
Clinical trial is the major tool to prove your innovation but post-marketing surveys (PMS) allow, under real-life conditions, to improve the knowledge on clinical and/or safety data, to establish risk management plan, and to support a long-term marketing development of your product.
PMS deal with marketed products that are prescribed in the usual manner and used in accordance with the approved label. There are no protocol-specific interventions/procedures. Therapeutic strategy, as well as decisions of management and follow-up, is strictly under the physician’s responsibility as per usual practice, and prescription is clearly separated from the decision to include the patient in the study. Moreover, epidemiological methods are used for statistical data analysis.
Which type of PMS for your study?
The study design is to be deeply discussed with our methodologists as the whole success of your project depends on it.
Here are the different types of PMS that can be proposed to you.
- Cohort studies and registries are an irreplaceable way to document real-life performance and safety of a drug.
- Case-control and other retrospective studies may be a great help in investigating rare adverse events.
- Cross-sectional surveys may be used to precise the epidemiology of a condition, for instance to identify the target population of a drug.
- Phone surveys and polls.
- Medico-economic evaluations.
- Post authorization safety studies (PASS): investigate the frequency of already known adverse events and possible rare adverse events not yet identified.
Our Services for your PMS:
- Methodological advice on study design
- Manage the regulatory aspects related to such types of studies,
- Preparation of study documents (protocol, questionnaires, information and consent form (ICF)…),
- Selection of investigation sites,
- Organizing meetings for investigators,
- Audits,
- Site initiation by visits or by phone calls,
- Data monitoring by follow-up visits, phone calls, fax or emails,
- Data management,
- Statistical analysis and report,
- Study report and other types of publications or communications.
As for clinical trials, each PMS is handled by a dedicated project manager who can rely on an international operational team composed of operation assistants and epidemiological research associates (ERAs) who are able to travel all over Europe for the needs of your study.
Please feel free to contact us for further information and a personalised advice.
News
Morning Read: Non-profit designing free Wi-Fi architecture for hospitals >> Read
Managing retinal vein occlusion >> Read
Let Me Die on the Prairie by Frances Jane Crosby Van Alstyne >> Read
Publication: Volume 16, number 4 (Stevenson). Study found that no conclusive results can be provided on the cost-effectiveness of four non-invasive tests for liver fibrosis [the Enhanced Liver Fibrosis Test, FibroTest and FibroMAX and transient elastography (FibroScan)] in patients suspected of having alcohol-related liver disease. >> Read
Top headlines from HIMSS2012 (Tuesday edition) >> Read
Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis >> Read
Publication: Volume 16, number 3 (Hockenhull). Report finds that whilst some interventions targeted at mental health populations to reduce violence are well supported by the evidence a scattergun approach in the research literature provides little firm evidence for the majority of interventions. Evidence shows small-to-moderate effects for cognitive behavioural therapy for psychological interventions, and larger effects for atypical antipsychotic drugs. >> Read
How the NHS measures up to other health systems >> Read
Publication: Volume 16, number 5 (Ara). Although orlistat, sibutramine and rimonabant are all effective at reducing weight and body mass index and, compared with placebo, are all cost-effective, both sibutramine and rimonabant have been withdrawn because of safety concerns relating to potential treatment-induced fatal adverse events. >> Read
Peter John Fenton >> Read
Publication: Volume 16, number 6 (Reeves). The verteporfin photodynamic therapy cohort study found that treatment and follow-up were much less frequent in routine clinical practice than in research trials and the cost-effectiveness was similar to the highest previous estimate. >> Read
Frederick Valentine Flynn >> Read